1. Modeling human hepatic steatosis in pluripotent stem cell-derived hepatocytes.
- Author
-
Sinton MC, Meseguer-Ripolles J, Lucendo-Villarin B, Drake AJ, and Hay DC
- Subjects
- Fatty Liver pathology, Hepatocytes pathology, Humans, Pluripotent Stem Cells pathology, Cell Differentiation, Fatty Liver metabolism, Hepatocytes metabolism, Models, Biological, Pluripotent Stem Cells metabolism
- Abstract
This protocol describes the production of hepatocyte-like cells (HLCs) from human pluripotent stem cells and how to induce hepatic steatosis, a condition characterized by intracellular lipid accumulation. Following differentiation to an HLC phenotype, intracellular lipid accumulation is induced with a steatosis induction cocktail, allowing the user to examine the cellular processes that underpin hepatic steatosis. Furthermore, the renewable nature of our system, on a defined genetic background, permits in-depth mechanistic analysis, which may facilitate therapeutic target identification in the future. For complete details on the use and execution of this protocol, please refer to Sinton et al. (2021)., Competing Interests: Professor David Hay is a founder, director, and shareholder in Stemnovate Limited., (© 2021 The Author(s).)
- Published
- 2021
- Full Text
- View/download PDF